Vertex Pharmaceuticals, Inc. (VRTX)
508.26
-8.08
(-1.56%)
USD |
NASDAQ |
Sep 18, 16:00
508.65
+0.39
(+0.08%)
After-Hours: 20:00
Vertex Pharmaceuticals 30-Day Average Daily Volume : 1.044M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.044M |
| September 16, 2026 | 1.061M |
| September 15, 2026 | 1.107M |
| September 14, 2026 | 1.130M |
| September 11, 2026 | 1.134M |
| September 10, 2026 | 1.146M |
| September 09, 2026 | 1.167M |
| September 08, 2026 | 1.192M |
| September 04, 2026 | 1.209M |
| September 03, 2026 | 1.224M |
| September 02, 2026 | 1.241M |
| September 01, 2026 | 1.226M |
| August 31, 2026 | 1.238M |
| August 28, 2026 | 1.235M |
| August 27, 2026 | 1.258M |
| August 26, 2026 | 1.276M |
| August 25, 2026 | 1.287M |
| August 24, 2026 | 1.298M |
| August 21, 2026 | 1.311M |
| August 20, 2026 | 1.323M |
| August 19, 2026 | 1.358M |
| August 18, 2026 | 1.386M |
| August 17, 2026 | 1.412M |
| August 14, 2026 | 1.426M |
| August 13, 2026 | 1.450M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.469M |
| August 11, 2026 | 1.493M |
| August 10, 2026 | 1.526M |
| August 07, 2026 | 1.726M |
| August 06, 2026 | 1.744M |
| August 05, 2026 | 1.761M |
| August 04, 2026 | 1.755M |
| August 03, 2026 | 1.756M |
| July 31, 2026 | 1.805M |
| July 30, 2026 | 1.824M |
| July 29, 2026 | 1.832M |
| July 28, 2026 | 1.833M |
| July 27, 2026 | 1.807M |
| July 24, 2026 | 1.794M |
| July 23, 2026 | 1.789M |
| July 22, 2026 | 1.774M |
| July 21, 2026 | 1.770M |
| July 20, 2026 | 1.784M |
| July 17, 2026 | 1.792M |
| July 16, 2026 | 1.792M |
| July 15, 2026 | 1.785M |
| July 14, 2026 | 1.782M |
| July 13, 2026 | 1.809M |
| July 10, 2026 | 1.816M |
| July 09, 2026 | 1.807M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Gilead Sciences, Inc. | 5.607M |
| Alnylam Pharmaceuticals, Inc. | 1.644M |
| Sionna Therapeutics, Inc. | 3.584M |
| Regeneron Pharmaceuticals, Inc. | 656937.0 |
| Amgen, Inc. | 2.520M |